Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20102
20111
20121
20131
20211
20221
20232
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Active, not recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Human Genome Sciences Inc., a GSK Company2
Novartis Pharmaceuticals2
Seoul National University Hospital2
Takeda2
Viatris Innovation GmbH2
Anthera Pharmaceuticals1
AstraZeneca1
Bristol-Myers Squibb1
Eli Lilly and Company1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases17
Immune System Diseases8
Lupus Erythematosus, Systemic8
Connective Tissue Diseases5
Arthritis, Rheumatoid2
Blood Platelet Disorders2
Cytopenia2
Glomerulonephritis2
Hematologic Diseases2
Hemorrhage2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.